Literature DB >> 17452466

Production of high-affinity human monoclonal antibody fab fragments to the 19-kilodalton C-terminal merozoite surface protein 1 of Plasmodium falciparum.

Xun-Jia Cheng1, Hitoshi Hayasaka, Katsuomi Watanabe, Yan-Lin Tao, Jin-Ye Liu, Hideo Tsukamoto, Toshihiro Horii, Kazuyuki Tanabe, Hiroshi Tachibana.   

Abstract

A combinatorial immunoglobulin gene library was constructed from peripheral blood lymphocytes of eight patients infected with Plasmodium falciparum and was screened for the production of human monoclonal antibody Fab fragments to the C-terminal 19-kDa fragment of P. falciparum merozoite surface protein 1 (MSP-1(19)). Three Fab clones recognized recombinant MSP-1(19) under nonreducing conditions. Indirect immunofluorescence microscopy demonstrated that three Fab clones stained the surfaces of late trophozoites/schizonts and merozoites of the FCR3 and 3D7 strains, suggesting the Fabs' reactivities to a conserved epitope. Sequence analysis of the heavy-chain genes revealed that the closest germ line V segments were VH1-8 and VH7-81, with 91% to 98% homology. The closest germ line D segment was D3-10, and the closest germ line J segment was JH4 or JH5, with 90% to 97% homology. In the light-chain genes, the closest germ line V segment was A27 for the Jkappa2, Jkappa4, and Jkappa5 segments. The dissociation constants of these Fab fragments for recombinant MSP-1(19) ranged from 1.09 x 10(-9) to 2.66 x 10(-9) M. The binding of the three Fab fragments to MSP-1(19) was competitively inhibited by the anti-MSP-1(19) mouse monoclonal antibody 12.8, which inhibits erythrocyte invasion by merozoites. However, the human Fab fragment with the highest affinity did not inhibit in vitro growth of P. falciparum. This is the first report of gene analysis and bacterial expression of human monoclonal antibodies to P. falciparum MSP-1(19). The combinatorial immunoglobulin gene library derived from malaria patients provides a potential tool for producing high-affinity human antibodies specific for P. falciparum.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17452466      PMCID: PMC1932930          DOI: 10.1128/IAI.00062-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  49 in total

1.  Human monoclonal anti-Plasmodium falciparum antibodies produced by stable EBV-transformed lymphocytes from patients with falciparum malaria.

Authors:  S Khusmith; S Tharavanij; M Chongsa-Nguan; P Tapchaisri; A Sabchareon; D Bunnag
Journal:  Southeast Asian J Trop Med Public Health       Date:  1987-03       Impact factor: 0.267

2.  Single-chain antigen-binding proteins.

Authors:  R E Bird; K D Hardman; J W Jacobson; S Johnson; B M Kaufman; S M Lee; T Lee; S H Pope; G S Riordan; M Whitlow
Journal:  Science       Date:  1988-10-21       Impact factor: 47.728

3.  Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro.

Authors:  C F Barbas; E Björling; F Chiodi; N Dunlop; D Cababa; T M Jones; S L Zebedee; M A Persson; P L Nara; E Norrby
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

4.  Human malaria parasites in continuous culture.

Authors:  W Trager; J B Jensen
Journal:  Science       Date:  1976-08-20       Impact factor: 47.728

5.  VH3 gene usage in neutralizing human antibodies specific for the Entamoeba histolytica Gal/GalNAc lectin heavy subunit.

Authors:  Hiroshi Tachibana; Katsuomi Watanabe; Xun-Jia Cheng; Hideo Tsukamoto; Yoshimasa Kaneda; Tsutomu Takeuchi; Seiji Ihara; William A Petri
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

6.  Fusion of two malaria vaccine candidate antigens enhances product yield, immunogenicity, and antibody-mediated inhibition of parasite growth in vitro.

Authors:  Weiqing Pan; Daqing Huang; Qingfeng Zhang; Li Qu; Dongmei Zhang; Xiaoli Zhang; Xiangyang Xue; Feng Qian
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

7.  Monoclonal anti-parasite and anti-RBC antibodies produced by stable EBV-transformed B cell lines from malaria patients.

Authors:  K Lundgren; M Wahlgren; M Troye-Blomberg; K Berzins; H Perlmann; P Perlmann
Journal:  J Immunol       Date:  1983-10       Impact factor: 5.422

8.  Initial extracellular development in vitro of merozoites of Plasmodium falciparum.

Authors:  W Trager; H N Lanners
Journal:  J Protozool       Date:  1984-11

9.  A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies.

Authors:  M J Blackman; H G Heidrich; S Donachie; J S McBride; A A Holder
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

10.  Malaria parasite-inhibitory antibody epitopes on Plasmodium falciparum merozoite surface protein-1(19) mapped by TROSY NMR.

Authors:  William D Morgan; Matthew J Lock; Thomas A Frenkiel; Munira Grainger; Anthony A Holder
Journal:  Mol Biochem Parasitol       Date:  2004-11       Impact factor: 1.759

View more
  10 in total

1.  Comparative study of IgA VH 3 gene usage in healthy TST(-) and TST(+) population exposed to tuberculosis: deep sequencing analysis.

Authors:  Siang Tean Chin; Joshua Ignatius; Siti Suraiya; Gee Jun Tye; Maria E Sarmiento; Armando Acosta; Mohd Nor Norazmi; Theam Soon Lim
Journal:  Immunology       Date:  2015-02       Impact factor: 7.397

2.  Modification of a human monoclonal antibody Fab fragment specific for Plasmodium falciparum 19-kDa C-terminal merozoite surface protein 1 by site-directed mutagenesis.

Authors:  Yan-Lin Tao; Xun-Jia Cheng; Yong-Feng Fu; Hideo Tsukamoto; Eisaku Yoshihara; Hiroshi Tachibana
Journal:  Parasitol Res       Date:  2008-04-30       Impact factor: 2.289

3.  Identification and Characterization of Functional Human Monoclonal Antibodies to Plasmodium vivax Duffy-Binding Protein.

Authors:  Lenore L Carias; Sebastien Dechavanne; Vanessa C Nicolete; Sokunthea Sreng; Seila Suon; Chanaki Amaratunga; Rick M Fairhurst; Celia Dechavanne; Samantha Barnes; Benoit Witkowski; Jean Popovici; Camille Roesch; Edwin Chen; Marcelo U Ferreira; Niraj H Tolia; John H Adams; Christopher L King
Journal:  J Immunol       Date:  2019-04-03       Impact factor: 5.422

4.  Generation of a neutralizing human monoclonal antibody Fab fragment to surface antigen 1 of Toxoplasma gondii tachyzoites.

Authors:  Yong-Feng Fu; Meng Feng; Kenji Ohnishi; Tamon Kimura; Johbu Itoh; Xun-Jia Cheng; Hiroshi Tachibana
Journal:  Infect Immun       Date:  2010-10-18       Impact factor: 3.441

Review 5.  Pathogenesis of malaria revisited.

Authors:  Prasad Dasari; Sucharit Bhakdi
Journal:  Med Microbiol Immunol       Date:  2012-09-07       Impact factor: 3.402

6.  Isolation, production and characterization of fully human monoclonal antibodies directed to Plasmodium falciparum MSP10.

Authors:  Dominika J Maskus; Susanne Bethke; Melanie Seidel; Stephanie Kapelski; Otchere Addai-Mensah; Alexander Boes; Güven Edgü; Holger Spiegel; Andreas Reimann; Rainer Fischer; Stefan Barth; Torsten Klockenbring; Rolf Fendel
Journal:  Malar J       Date:  2015-07-16       Impact factor: 2.979

7.  A case of human infection with a novel Babesia species in China.

Authors:  Su-Qin Man; Ke Qiao; Jie Cui; Meng Feng; Yong-Feng Fu; Xun-Jia Cheng
Journal:  Infect Dis Poverty       Date:  2016-03-29       Impact factor: 4.520

8.  Characterization of a novel inhibitory human monoclonal antibody directed against Plasmodium falciparum Apical Membrane Antigen 1.

Authors:  Dominika J Maskus; Michał Królik; Susanne Bethke; Holger Spiegel; Stephanie Kapelski; Melanie Seidel; Otchere Addai-Mensah; Andreas Reimann; Torsten Klockenbring; Stefan Barth; Rainer Fischer; Rolf Fendel
Journal:  Sci Rep       Date:  2016-12-21       Impact factor: 4.379

Review 9.  Phage Display in the Quest for New Selective Recognition Elements for Biosensors.

Authors:  Riikka Peltomaa; Elena Benito-Peña; Rodrigo Barderas; María C Moreno-Bondi
Journal:  ACS Omega       Date:  2019-07-03

10.  Selection of binding targets in parasites using phage-display and aptamer libraries in vivo and in vitro.

Authors:  R R Tonelli; W Colli; M J M Alves
Journal:  Front Immunol       Date:  2013-01-09       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.